Multiattribute probabilistic prostate elastic registration (MAPPER): Application to fusion of ultrasound and magnetic resonance imaging. Issue 3 (10th February 2015)

• Record Type: Journal Article
• Authors: Sparks, Rachel; Nicolas Bloch, B.; Feleppa, Ernest; Barratt, Dean; Moses, Daniel; Ponsky, Lee; Madabhushi, Anant
• Is Part Of: Medical physics. Volume 42:Issue 3(2015)
• Page Start: 1153
• Page End: 1163
• Publication Date: 2015-02-10
• Subjects: biomedical MRI -- biomedical ultrasonics -- cancer -- image fusion -- image registration -- image segmentation -- medical image processing; Clinical applications -- Ultrasonographic imaging -- Cancer -- Registration -- Segmentation; Involving electronic [emr] or nuclear [nmr] magnetic resonance, e.g. magnetic resonance imaging -- Diagnosis using ultrasonic, sonic or infrasonic waves -- Biological material, e.g. blood, urine; Haemocytometers -- Digital computing or data processing equipment or methods, specially adapted for specific applications -- Image data processing or generation, in general; image registration -- MRI‐ultrasound fusion -- prostate cancer -- prostate imaging -- image‐guided biopsy; Ultrasonography -- Magnetic resonance imaging -- Cancer -- Wave attenuation -- Radiologists -- Wavelets -- Medical image quality -- Ultrasonic attenuation -- Tissues; Medical physics -- Periodicals; Medical physics; Geneeskunde; Natuurkunde; Toepassingen; Biophysics; Periodicals; Periodicals; Electronic journals; 610.153
• DOI: 10.1118/1.4905104
• Languages: English
• ISSNs: 0094-2405

Abstract

Abstract : Purpose: Transrectal ultrasound (TRUS)‐guided needle biopsy is the current gold standard for prostate cancer diagnosis. However, up to 40% of prostate cancer lesions appears isoechoic on TRUS. Hence, TRUS‐guided biopsy has a high false negative rate for prostate cancer diagnosis. Magnetic resonance imaging (MRI) is better able to distinguish prostate cancer from benign tissue. However, MRI‐guided biopsy requires special equipment and training and a longer procedure time. MRI‐TRUS fusion, where MRI is acquired preoperatively and then aligned to TRUS, allows for advantages of both modalities to be leveraged during biopsy. MRI‐TRUS‐guided biopsy increases the yield of cancer positive biopsies. In this work, the authors present multiattribute probabilistic postate elastic registration (MAPPER) to align prostate MRI and TRUS imagery. Methods: MAPPER involves (1) segmenting the prostate on MRI, (2) calculating a multiattribute probabilistic map of prostate location on TRUS, and (3) maximizing overlap between the prostate segmentation on MRI and the multiattribute probabilistic map on TRUS, thereby driving registration of MRI onto TRUS. MAPPER represents a significant advancement over the current state‐of‐the‐art as it requires no user interaction during the biopsy procedure by leveraging texture and spatial information to determine the prostate location on TRUS. Although MAPPER requires manual interaction to segment the prostate on MRI, this step is performed prior to biopsy and will not substantially increase biopsy procedure time. Results: MAPPER was evaluated on 13 patient studies from two independent datasets—Dataset 1 has 6 studies acquired with a side‐firing TRUS probe and a 1.5 T pelvic phased‐array coil MRI; Dataset 2 has 7 studies acquired with a volumetric end‐firing TRUS probe and a 3.0 T endorectal coil MRI. MAPPER has a root‐mean‐square error (RMSE) for expert selected fiducials of 3.36 ± 1.10 mm for Dataset 1 and 3.14 ± 0.75 mm for Dataset 2. State‐of‐the‐art MRI‐TRUS fusion methods report RMSE of 3.06–2.07 mm. Conclusions: MAPPER aligns MRI and TRUS imagery without manual intervention ensuring efficient, reproducible registration. MAPPER has a similar RMSE to state‐of‐the‐art methods that require manual intervention.